Tod Smeal
Hoofd Techniek/Wetenschap/O&O bij CARDIFF ONCOLOGY, INC.
Vermogen: - $ op 31-05-2024
Profiel
Tod Smeal is currently the Chief Scientific Officer at Cardiff Oncology, Inc. He previously held positions as the Director-Oncology Research Unit at Pfizer Inc. from 2003 to 2015, the Chief Scientific Officer at Eli Lilly & Co. from 2015 to 2020, and the Chief Scientific Officer at Hexagon Bio, Inc. from 2020 to 2021.
Dr. Smeal obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California San Diego.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
-.--% | 07-03-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Tod Smeal
Bedrijven | Functie | Begin |
---|---|---|
CARDIFF ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 11-01-2022 |
Eerdere bekende functies van Tod Smeal
Bedrijven | Functie | Einde |
---|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
ELI LILLY AND COMPANY | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
PFIZER, INC. | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Tod Smeal
Massachusetts Institute of Technology | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
PFIZER, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |